Ulrich Meißner

Ulrich Meissner is an experienced independent consultant and angel investor, active in the investment community since 2011 through Meissner Marketing Communications Consulting. Currently serving as a senior advisor and angel investor at ginmon since September 2017, Ulrich Meissner also supports various startups, including BRbase and Myria Biosciences AG, where involvement began in March and January 2024, respectively. Additionally, Ulrich Meissner has invested in numerous other companies such as Solios Diagnostics GmbH, BIOVOX GmbH, and Grandperspective GmbH. Educational qualifications include a Ph.D. in English Literature and a Master's degree in Mathematics and Language Arts, both from the University of Mannheim.